Social Determinants and a Diabetes Prevention Program Tailored for African Americans
Part of paid clinical trials in Kansas City, Missouri.
- Sponsor
- University of Missouri, Kansas City
- Study ID
- NCT05301413
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Overweight and Obesity
- PreDiabetes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Culturally Tailored Diabetes Prevention Program — BEHAVIORALThis intervention includes a culturally tailored DPP curriculum, class procedures, and handouts
- Culturally Tailored DPP Enhanced with Socioeconomic Supports — BEHAVIORALThis intervention includes the culturally tailored DPP curriculum, class procedures, and handouts along with promotional items for class participation, opportunities to attend class in-person or virtually through a digital platform, and assistance from a community health worker to provide linkage to health care services and community resources
- Diabetes Prevention Program — BEHAVIORALThis is the CDC TD2 evidence-based Diabetes Prevention Program
Study Details
African Americans (AAs) have rates of diabetes mellitus (DM) twice that of Whites and are disproportionately affected by leading risk factors for DM - obesity and low-income. A critical strategy in the battle against DM is the Diabetes Prevention Program (DPP), an evidence-based intervention that significantly delays or prevents Type 2 diabetes through the promotion of diet change, exercise and modest weight loss. However, weight loss from the DPP among AAs is about half that of White participants, and suboptimal AA attendance is a critical contributor. The investigators propose to conduct a study that will address social determinants (SD) that challenge DPP attendance with underserved African Americans from a safety net hospital. The investigators will examine DPP attendance and weight loss with participants randomized to 3 groups: standard DPP, a culturally-tailored DPP to address acceptability, and a culturally-tailored DPP enhanced to address socioeconomic-related barriers to DPP participation. This novel study is the first to tailor the DPP to address SD cultural and socioeconomic barriers that limit DPP attendance and reduce its effectiveness on outcomes. The proposed multidimensional, SD tailored DPP has great potential to be a feasible and scalable model to reduce DM risks among urban, African Americans and ultimately reduce DM disparities.
Key Dates
- Start date
- Jul 20, 2022
- Status verified
- May 2025
- Primary completion
- Dec 31, 2025
- Completion
- Feb 28, 2026
Study Design
- Enrollment
- 360 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: StandardStandard Diabetes Prevention Program (DPP)
- Experimental: Culturally Tailored DPPDPP culturally tailored for African Americans
- Experimental: Culturally Tailored DPP Enhanced with Socioeconomic SupportsCulturally tailored DPP plus promotions for class attendance, hybrid attendance (in-person and virtual), and linkage to care services provided by a community health worker
Primary Outcome Measure
Percent Weight Loss [ Time Frame: 6 months ]
Central Contacts
- Christopher Winders18162355370
- Carole Bowe Thompson8162356062
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Health | Kansas City | Missouri | 64108 | Betty Drees (SUB_INVESTIGATOR) |
| University of Missouri-Kansas City | Kansas City | Missouri | 64108 | Jannette Berkley-Patton, PhD 816-235-6362 |
Find similar trials in Kansas City, MO
Related Studies
- The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectEnrolling By Invitation · Marinella Temprosa · Phoenix, Arizona
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsRecruiting · Cleerly, Inc. · Chandler, Arizona
- Blood Markers of Early Pancreas CancerRecruiting · University of Nebraska · Omaha, Nebraska
- Bromocriptine for Patients With Schizophrenia and PrediabetesPHASE4 · Not Yet Recruiting · VA Pittsburgh Healthcare System · Pittsburgh, Pennsylvania